Clinical Disorder Treatment Market Analysis

The market is segmented by drug class into antidepressants, anticonvulsants, anxiolytics, atypical antipsychotics, and noradrenergic agents, out of which, the antidepressants segment is anticipated to hold the largest share in the global clinical disorder treatment market. This can be accounted to the high efficacy rate of antidepressants in lowering an individual’s depressive state of mind as compared to other available medications. Apart from these, increasing number of pipeline candidates and product approvals of antidepressants is also predicted to boost the market segment growth in the future. Additionally, on the basis of drug distribution channel, the hospital pharmacy segment is assessed to acquire the largest share during the forecast period owing to the increasing patient visits in hospitals, and high preference of patients to get treatment from hospitals. 

Our in-depth analysis of the global market includes the following segments: